Android app Apple app link

Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

By Yahoo! Finance   |   1 year ago
Vivos Therapeutics Inc (VVOS) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

Vivos Therapeutics Inc (NASDAQ:VVOS) had positive Q3 2024 results, with increased revenue and gross margin, reduced operating expenses, and FDA clearance for treating severe OSA.

Read More

Did you find this insightful?

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.